101 related articles for article (PubMed ID: 21255065)
1. Glypican 3 is a sensitive, but not a specific, marker for the diagnosis of yolk sac tumours.
Preda O; Nicolae A; Aneiros-Fernández J; Borda A; Nogales FF
Histopathology; 2011 Jan; 58(2):312-4; author reply 314-5. PubMed ID: 21255065
[No Abstract] [Full Text] [Related]
2. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
[TBL] [Abstract][Full Text] [Related]
3. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Zynger DL; McCallum JC; Luan C; Chou PM; Yang XJ
Histopathology; 2010 May; 56(6):750-7. PubMed ID: 20546340
[TBL] [Abstract][Full Text] [Related]
4. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors.
Gonzalez-Roibon N; Katz B; Chaux A; Sharma R; Munari E; Faraj SF; Illei PB; Torbenson M; Netto GJ
Hum Pathol; 2013 Jul; 44(7):1293-9. PubMed ID: 23347651
[TBL] [Abstract][Full Text] [Related]
6. Solid pattern yolk sac tumor: a morphologic and immunohistochemical study of 52 cases.
Kao CS; Idrees MT; Young RH; Ulbright TM
Am J Surg Pathol; 2012 Mar; 36(3):360-7. PubMed ID: 22261704
[TBL] [Abstract][Full Text] [Related]
7. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
8. Yolk sac tumours revisited. A review of their many faces and names.
Nogales FF; Preda O; Nicolae A
Histopathology; 2012 Jun; 60(7):1023-33. PubMed ID: 22008025
[TBL] [Abstract][Full Text] [Related]
9. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
Cao D; Humphrey PA; Allan RW
Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862
[TBL] [Abstract][Full Text] [Related]
10. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma.
Cao D; Lane Z; Allan RW; Wang P; Guo CC; Peng Y; Li J
Histopathology; 2010 Jul; 57(1):152-7. PubMed ID: 20553335
[No Abstract] [Full Text] [Related]
11. Yolk sac tumor of the testis.
Cao D; Humphrey PA
J Urol; 2011 Oct; 186(4):1475-6. PubMed ID: 21855901
[No Abstract] [Full Text] [Related]
12. [Infantile testicular tumor (yolk sac tumor): a case report].
Muraoka K; Yokonisi T; Matsumoto T; Umemoto S; Shioi K; Komiya A; Tomoda T; Yoshida M; Takase K; Oogo Y; Kobayashi K; Noguchi S; Kishi H
Hinyokika Kiyo; 2009 Jun; 55(6):367-70. PubMed ID: 19588873
[TBL] [Abstract][Full Text] [Related]
13. A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac.
Nogales FF; Quiñonez E; López-Marín L; Dulcey I; Preda O
Histopathology; 2014 Jul; 65(1):51-9. PubMed ID: 24444105
[TBL] [Abstract][Full Text] [Related]
14. Glypican 3: a novel marker in testicular germ cell tumors.
Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
[TBL] [Abstract][Full Text] [Related]
15. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
Cao D; Li J; Guo CC; Allan RW; Humphrey PA
Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
[TBL] [Abstract][Full Text] [Related]
16. Ovarian endometrioid carcinoma with yolk sac component in a young patient: a diagnostic and therapeutic dilemma.
Kane SV; Wuntkal R; Ramadwar M; Tongaonkar HB
Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):364-6. PubMed ID: 15282017
[No Abstract] [Full Text] [Related]
17. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
Kandil DH; Cooper K
Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
[TBL] [Abstract][Full Text] [Related]
18. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
19. SALL4 and SF-1 are sensitive and specific markers for distinguishing granulosa cell tumors from yolk sac tumors.
Bai S; Wei S; Ziober A; Yao Y; Bing Z
Int J Surg Pathol; 2013 Apr; 21(2):121-5. PubMed ID: 22832114
[TBL] [Abstract][Full Text] [Related]
20. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Di Filippo G; Franchini E; Massari F; Mollica V; Tateo V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
Histopathology; 2023 Sep; 83(3):465-476. PubMed ID: 37317674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
